Related Experiment Video

Updated: Jun 18, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Use of cell lines in the investigation of pharmacogenetic loci

Wei Zhang1, M Eileen Dolan

  • 1Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.

Current Pharmaceutical Design
|November 21, 2009
PubMed

Insights

Pharmacogenomic research uses cell lines to study how genetic variations influence drug response and toxicity. This approach helps predict individual patient reactions to medications, improving treatment efficacy and safety.

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Toxicology

Background:

  • Individual variability in drug response and toxicity is influenced by genetic and non-genetic factors.
  • Pharmacogenomics seeks to personalize drug therapy for optimal efficacy and minimal toxicity.
  • Cell lines serve as valuable models for studying cellular drug effects, including cytotoxicity and biochemical reactions.

Purpose of the Study:

  • To explore the utility of cell lines in pharmacogenomic discovery for predicting drug response and toxicity.
  • To investigate how human genetic variation impacts cellular responses to drugs, particularly chemotherapeutics.
  • To assess the potential of genome-wide association studies in cell line models for identifying genetic associations with drug effects.

Main Methods:

  • Utilizing cell lines derived from diverse individuals as model systems for drug response studies.
  • Employing traditional candidate gene approaches to analyze specific genetic factors.
  • Implementing genome-wide association (GWA) studies on cell lines with extensive genotypic and phenotypic data.

Main Results:

  • Cell lines provide a safe and ethical model to study the effects of potentially toxic drugs, like chemotherapeutics.
  • Genome-wide association studies in cell line models enable comprehensive testing of the human genome for drug response associations.
  • The integration of genetic and non-genetic data in cell line models shows promise for predicting individual drug toxicity.

Conclusions:

  • Cell lines are effective models for pharmacogenomic research, aiding in the understanding of drug response and toxicity.
  • Genome-wide association studies using cell lines can identify genetic determinants of drug response.
  • Further development of these models holds potential for a comprehensive approach to predicting individual drug outcomes, especially for anticancer drugs.

More Related Videos

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...